A tooth under attack does not just hurt. It sends out a distress signal that can finish the job an injury started, and new research suggests red light may be able to intercept that signal before the damage becomes permanent.
A study published in Archives of Oral Biology in November 2026 found that photobiomodulation, the clinical term for therapeutic red and near-infrared light, reduced the release of distress molecules from stressed odontoblasts and improved how many of those cells survived. Odontoblasts are the specialized cells that build and maintain dentin, the layer just beneath tooth enamel, and they cannot be easily replaced once a large share of them dies off.
Why a damaged tooth cell becomes its own worst enemy
When odontoblasts are injured by decay, trauma, or an aggressive dental procedure, they do not simply die quietly. They release a class of molecules called damage-associated molecular patterns, or DAMPs, which include fragments like ATP, heat-shock proteins, and the nuclear protein HMGB1.
These molecules are normally kept inside the cell. Once they leak out, they bind to pattern-recognition receptors, including toll-like receptors and RAGE, on nearby cells, and the immune system reads that binding as an alarm.
That alarm triggers inflammation meant to protect the tissue. Inside a tooth, where space is tight and blood supply is limited, the same inflammatory response can cut off its own escape route and accelerate the death of surrounding pulp cells rather than contain the original injury.
Dentists have long known that aggressive pulp inflammation, a condition called pulpitis, often ends in a root canal once enough odontoblasts and pulp tissue die off. Root canal therapy remains one of the most common restorative procedures in dentistry precisely because once that cascade runs its course, there is little pulp tissue left to save. The new study was designed to test whether interrupting the DAMP signal earlier could change that trajectory.
What photobiomodulation actually did to the cells
Photobiomodulation uses specific wavelengths of red and near-infrared light, typically in the 600 to 850 nanometer range, to interact with a mitochondrial enzyme called cytochrome c oxidase. That interaction can increase ATP production, modulate reactive oxygen species, and shift how a stressed cell responds to injury rather than simply overwhelming it with energy.
In the Archives of Oral Biology study, researchers exposed stressed odontoblasts to photobiomodulation and tracked both DAMP release and cell survival. Light exposure measurably reduced the DAMP signaling cascade and left a higher proportion of odontoblasts intact compared with untreated, equally stressed cells.
That matters because odontoblasts do not regenerate the way skin or gut lining does. Once a large population of them dies inside a tooth, the body has limited capacity to replace them, which is part of why irreversible pulpitis so often ends in removal of the pulp rather than repair.
A treatment that calms the DAMP cascade before that tipping point, rather than one that only numbs pain or fights bacteria, represents a different strategy than the antiseptics and medicated fillings that currently define conservative pulp therapy.
The same light, a very different target
The wavelengths involved overlap substantially with the at-home red light panels already used for skin and muscle recovery, including devices reviewed on this site like the Hooga Pro and the Joovv Solo 3.0. Those panels were not designed or tested for intraoral use, and this study did not test them.
What it does show is that the underlying mechanism, a mitochondrial response to specific red and near-infrared wavelengths, operates in tissue well beyond skin and joints. Dental researchers have already explored low-level laser therapy for sensitive teeth, orthodontic pain, and minor soft-tissue healing in the mouth, and this study adds a more specific mechanistic explanation for why it might help pulp survive an injury rather than just reducing pain perception.
Dentistry has been slower than sports medicine or dermatology to adopt photobiomodulation clinically, partly because delivering consistent light dosing inside a tooth or pulp chamber is a harder engineering problem than irradiating skin. A dental handpiece or fiber-optic probe calibrated for intrapulpal delivery is a different device than a wall-mounted panel, and none currently exists for this specific indication.
Why this is not a reason to point a home device at a toothache
The study was conducted on isolated odontoblasts in a laboratory setting, not inside a living tooth, and not in a human mouth. Cell culture work consistently overstates how cleanly a mechanism translates into a clinical outcome, because it strips away blood flow, immune complexity, and the mechanical reality of dentin and enamel blocking most external light from reaching the pulp chamber.
There is also no established dose, wavelength, or delivery method for intraoral photobiomodulation that has cleared clinical trials for pulp preservation. The parameters that worked on cultured cells in a dish will not automatically match what is safe or effective to aim through a tooth, and skin-facing red light panels are not built to solve that problem.
Pulpitis that has progressed to spontaneous, lingering pain is still a case for a dentist, not a light panel. What this research supports is a rationale for future clinical trials of targeted, in-office photobiomodulation devices as an adjunct to conservative pulp therapy, not a new home remedy.
Where the science goes from here
The logical next step is testing whether photobiomodulation delivered through an actual tooth structure, rather than directly onto cultured cells, still meaningfully reduces DAMP signaling. Researchers would also need to establish whether the effect holds in teeth with active bacterial infection, since this study isolated the DAMP mechanism without that added variable.
If those trials confirm a clinical benefit, the appeal is obvious: a light-based adjunct that helps preserve a tooth’s own pulp tissue would sit well ahead of antiseptics and medicated fillings that only manage the aftermath of cell death. For now, the finding is a genuine mechanistic lead, not a treatment, and the gap between a petri dish and a dental chair is where most promising biology still goes to die.
